CIENCIASMEDICASNEWS: Medical News | Medical Articles: A comprehensive toolkit for SARS-CoV-2 research

viernes, 9 de octubre de 2020

Medical News | Medical Articles: A comprehensive toolkit for SARS-CoV-2 research

	Antibodies
	The latest antibodies news from News Medical

VHH Antibodies (Nanobodies) Advantages and Limitations

A comprehensive toolkit for SARS-CoV-2 research

Sino Biological has developed a comprehensive collection of SARS-CoV-2 research tools to support the development of vaccines, therapeutic antibodies and immunodiagnostic assays, and the basic research - over 200 research papers have cited these reagents that have been published in Cell, Nature, Science, etc.

Find Out More

			Researchers identify a new method to synthesize miniaturized antibodies Scientists have identified a new method to synthesize miniaturized antibodies, paving the way for a promising new class of therapies for various diseases.

			What is an Antigen? Any substance that induces the immune system to produce antibodies against it is called an antigen.

	About 10% patients with severe disease create auto-antibodies that attack the immune system People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients' immune systems.

	New Dual CAR T cell immunotherapy can help fight against HIV infection A recent study published in the journal Nature Medicine, led by researchers James Riley, PhD, a professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, and Todd Allen, PhD, a professor of Medicine at Harvard Medical School and Group Leader at the Ragon Institute of MGH, MIT and Harvard, describes a new Dual CAR T cell immunotherapy that can help fight HIV infection

	CAR T cell therapy can predict treatment outcomes in patients with large B-cell lymphoma Scientists have identified cellular and molecular features of anti-CD19 CAR T cell infusion products that are correlated with large B-cell lymphoma (LBCL).

	Novel immunotherapy platform can connect mussel adhesive proteins to the antibodies Antibody-based immunotherapy is one of treatment options for cancer immunotherapy by modulating our immune system with therapeutic antibodies.